Menu
GeneBe

CD34

CD34 molecule, the group of CD molecules

Basic information

Region (hg38): 1:207880971-207911402

Links

ENSG00000174059NCBI:947OMIM:142230HGNC:1662Uniprot:P28906AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CD34 gene.

  • Inborn genetic diseases (16 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD34 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
15
clinvar
2
clinvar
17
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 15 2 0

Variants in CD34

This is a list of pathogenic ClinVar variants found in the CD34 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-207887761-C-G not specified Uncertain significance (Sep 22, 2023)3140559
1-207887802-C-T not specified Uncertain significance (Sep 16, 2021)2226700
1-207887810-G-T not specified Uncertain significance (Aug 30, 2022)2309528
1-207887868-G-T not specified Uncertain significance (Nov 18, 2023)3140558
1-207887922-C-T not specified Uncertain significance (Jan 03, 2022)2332136
1-207888696-T-A not specified Uncertain significance (Jan 22, 2024)3140563
1-207888710-C-T not specified Uncertain significance (Aug 12, 2021)2222431
1-207888713-C-T not specified Uncertain significance (Mar 29, 2022)2386805
1-207889175-A-G not specified Uncertain significance (Jul 17, 2023)2590906
1-207889189-A-C not specified Uncertain significance (Jun 07, 2023)2558829
1-207889554-G-A not specified Uncertain significance (Aug 31, 2022)2309960
1-207889565-C-G not specified Uncertain significance (Jun 06, 2022)2230559
1-207899011-G-A not specified Uncertain significance (Sep 16, 2021)2385816
1-207899084-C-A not specified Uncertain significance (Dec 01, 2022)2379871
1-207899110-C-T Likely benign (Aug 16, 2018)725461
1-207899825-G-C not specified Uncertain significance (Jan 27, 2022)2274001
1-207899829-T-C not specified Uncertain significance (Jun 22, 2023)2605428
1-207899844-T-C not specified Likely benign (Oct 06, 2023)3140561
1-207899877-C-T not specified Uncertain significance (Oct 14, 2023)3140560
1-207899944-C-G not specified Uncertain significance (Aug 08, 2023)2617540
1-207899974-C-T not specified Likely benign (Oct 20, 2021)2207158
1-207911029-T-G not specified Uncertain significance (Aug 05, 2023)2589328

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CD34protein_codingprotein_codingENST00000310833 827154
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000004990.8701257170311257480.000123
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7731752060.8490.00001032433
Missense in Polyphen9285.3341.0781962
Synonymous0.4548287.40.9380.00000479819
Loss of Function1.491117.80.6199.30e-7209

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004490.000448
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.0001510.000149
Middle Eastern0.00005440.0000544
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Possible adhesion molecule with a role in early hematopoiesis by mediating the attachment of stem cells to the bone marrow extracellular matrix or directly to stromal cells. Could act as a scaffold for the attachment of lineage specific glycans, allowing stem cells to bind to lectins expressed by stromal cells or other marrow components. Presents carbohydrate ligands to selectins.;
Pathway
Cell adhesion molecules (CAMs) - Homo sapiens (human);Hematopoietic cell lineage - Homo sapiens (human);Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System;C-MYB transcription factor network (Consensus)

Recessive Scores

pRec
0.879

Intolerance Scores

loftool
0.894
rvis_EVS
0.22
rvis_percentile_EVS
68.27

Haploinsufficiency Scores

pHI
0.0422
hipred
N
hipred_score
0.179
ghis
0.464

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.105

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cd34
Phenotype
immune system phenotype; hematopoietic system phenotype; neoplasm; homeostasis/metabolism phenotype; cellular phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);

Gene ontology

Biological process
tissue homeostasis;endothelial cell proliferation;glomerular filtration;endothelium development;signal transduction;regulation of blood pressure;cell population proliferation;positive regulation of gene expression;negative regulation of gene expression;hemopoiesis;negative regulation of blood coagulation;negative regulation of tumor necrosis factor production;positive regulation of interleukin-10 production;mesangial cell-matrix adhesion;paracrine signaling;positive regulation of odontogenesis;negative regulation of nitric oxide biosynthetic process;positive regulation of angiogenesis;cell motility;regulation of immune response;leukocyte migration;transdifferentiation;vascular wound healing;hematopoietic stem cell proliferation;positive regulation of transforming growth factor beta production;positive regulation of granulocyte colony-stimulating factor production;extracellular exosome assembly;glomerular endothelium development;stem cell proliferation;metanephric glomerular mesangial cell differentiation;cell-cell adhesion;negative regulation of cellular response to heat;negative regulation of cellular response to hypoxia;negative regulation of interleukin-2 secretion;positive regulation of glial cell-derived neurotrophic factor secretion;negative regulation of neuron death;positive regulation of vasculogenesis
Cellular component
cytoplasm;lysosome;plasma membrane;integral component of plasma membrane;external side of plasma membrane;basal plasma membrane;apical plasma membrane;glomerular endothelium fenestra;intercellular bridge;perinuclear region of cytoplasm
Molecular function
transcription factor binding;carbohydrate binding;sulfate binding